TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
ATYR

aTyr Pharma, Inc.

Healthcare · Biotechnology

0.363$ -3.6% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Balance Sheet

aTyr Pharma, Inc. (ATYR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 94 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ATYR
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
21 130 81 89 53 36 39 116 96 121 97 94
17 98 75 87 51 32 36 114 81 103 82 80
14 53 38 21 23 9.2 17 2.3 10.0 23 11 11
16 96 72 85 50 31 32 108 66 98 72 79
0.1 2.0 0.4 12 2.4 1.7 0.9
112 15 18 25 19 15 7.2 6.4 25 30 27 27
10 12 8.5 10 11 13 5.9 6.0 14 16 15 15
5.1 3.4 0.3 5.0 7.8 9.5 0.9 1.0 0.9 1.3 1.3 1.5
1.4 3.9 2.6 2.3 1.0 0.8 1.4 1.0 3.1 3.5 4.3 3.9
-91 115 63 64 34 21 32 109 71 91 70 67
-110 -158 -216 -264 -299 -322 -339 -372 -418 -468 -532 -606
0.1 1.1 1.7 1.8 2.1 3.4 9.2 19 28 54 74 93

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?